Low magnesium levels are involved in oxide nitric production, subsequent vascular-endothelial growth factor (VEGF) production and neoangiogenesis [148], but conflicting data are found in the literature about magnesium supplementation in breast cancer and its clinical significance. This evidence concerns the gene VEGFA and breast carcinoma.